These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33693866)

  • 1. Hepatoprotective Effects of Indole, a Gut Microbial Metabolite, in Leptin-Deficient Obese Mice.
    Knudsen C; Neyrinck AM; Leyrolle Q; Baldin P; Leclercq S; Rodriguez J; Beaumont M; Cani PD; Bindels LB; Lanthier N; Delzenne NM
    J Nutr; 2021 Jun; 151(6):1507-1516. PubMed ID: 33693866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indole alleviates nonalcoholic fatty liver disease in an ACE2-dependent manner.
    Gao Y; Chen Q; Yang S; Cao J; Li F; Li R; Wu Z; Wang Y; Yuan L
    FASEB J; 2024 Sep; 38(18):e70061. PubMed ID: 39305120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced liver steatosis accompanies an increase in hepatic inflammation, colonic, secondary bile acids and Lactobacillaceae/Lachnospiraceae bacteria in C57BL/6 mice fed a high-fat diet.
    Zeng H; Larson KJ; Cheng WH; Bukowski MR; Safratowich BD; Liu Z; Hakkak R
    J Nutr Biochem; 2020 Apr; 78():108336. PubMed ID: 32004929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
    Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
    Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
    Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
    J Obes; 2013; 2013():296537. PubMed ID: 23401753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin administration restores the altered adipose and hepatic expression of aquaglyceroporins improving the non-alcoholic fatty liver of ob/ob mice.
    Rodríguez A; Moreno NR; Balaguer I; Méndez-Giménez L; Becerril S; Catalán V; Gómez-Ambrosi J; Portincasa P; Calamita G; Soveral G; Malagón MM; Frühbeck G
    Sci Rep; 2015 Jul; 5():12067. PubMed ID: 26159457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
    Ding Y; Yanagi K; Yang F; Callaway E; Cheng C; Hensel ME; Menon R; Alaniz RC; Lee K; Jayaraman A
    Elife; 2024 Feb; 12():. PubMed ID: 38412016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3.
    Ma L; Li H; Hu J; Zheng J; Zhou J; Botchlett R; Matthews D; Zeng T; Chen L; Xiao X; Athrey G; Threadgill DW; Li Q; Glaser S; Francis H; Meng F; Li Q; Alpini G; Wu C
    Hepatology; 2020 Oct; 72(4):1191-1203. PubMed ID: 31953865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.
    Suriano F; Vieira-Silva S; Falony G; Roumain M; Paquot A; Pelicaen R; Régnier M; Delzenne NM; Raes J; Muccioli GG; Van Hul M; Cani PD
    Microbiome; 2021 Jun; 9(1):147. PubMed ID: 34183063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
    Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
    World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor type 3 antagonists improve obesity-associated fatty liver disease in mice.
    Haub S; Ritze Y; Ladel I; Saum K; Hubert A; Spruss A; Trautwein C; Bischoff SC
    J Pharmacol Exp Ther; 2011 Dec; 339(3):790-8. PubMed ID: 21903748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of Ilexhainanoside D and ilexsaponin A
    Zhao W; Xiao M; Yang J; Zhang L; Ba Y; Xu R; Liu Z; Zou H; Yu P; Wu X; Chen X
    Phytomedicine; 2019 Oct; 63():153039. PubMed ID: 31387054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea extract protects leptin-deficient, spontaneously obese mice from hepatic steatosis and injury.
    Bruno RS; Dugan CE; Smyth JA; DiNatale DA; Koo SI
    J Nutr; 2008 Feb; 138(2):323-31. PubMed ID: 18203899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of bifid triple viable on chronic low-grade inflammation in obese mice induced by high fat diet].
    Lu M; Yuan L; Hu N; Zhong X; Jiang Y; Lin M; Lu X
    Wei Sheng Yan Jiu; 2022 Sep; 51(5):797-802. PubMed ID: 36222043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of bile acid sequestration on hepatic steatosis in obese mice.
    Solís N; Pizarro M; Quintero P; Arab JP; Riquelme A; Padilla O; Carrasco G; Pirola CJ; Sookoian S; Arrese M
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):105-12. PubMed ID: 24378273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.
    Wang P; Wang J; Li D; Ke W; Chen F; Hu X
    J Nutr Biochem; 2020 Jul; 81():108363. PubMed ID: 32388250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.